Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, oral for treating osteoporosis

CCG Approval Status:

Date Added: 29 - Sep - 2022
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of ORAL BISPHOSPHONATES (alendronic acid, ibandronic acid and risedronate sodium) for treating osteoporosis in accordance with NICE TA464.

NHS Cheshire and Merseyside PENDING APPROVAL